ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 421921 | Rec_0434579 | EHPVL |
EHPVL |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (ACE) |
54.80 ± 2.17 % | ACE inhibition at 10 mM (HHL colorimetric assay) |
31145747 | - |
YES |
| 421922 | Rec_0434580 | BPP-Brachy (native non-amidated form) |
WPPPKVSP |
Brachycephalus ephippium [Animal] |
- |
- |
- | MALDI-TOF/TOF MS/MS de novo sequencing |
26661890 | - |
YES |
| 421923 | Rec_0434581 | BPP-BrachyNH2 (native amidated form) |
WPPPKVSP |
Brachycephalus ephippium [Animal] |
- |
- |
- | MALDI-TOF/TOF MS/MS de novo sequencing |
26661890 | - |
YES |
| 421924 | Rec_0434582 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rattus norvegicus thoracic aorta; endothelium intact (E+) |
40.3 ± 3.5 % | Maximum vasorelaxation (Emax); endothelium intact (E+) |
26661890 | - |
YES |
| 421925 | Rec_0434583 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rattus norvegicus thoracic aorta; endothelium removed (E−) |
14.7 ± 4.1 % | Maximum vasorelaxation (Emax); endothelium removed (E−) |
26661890 | - |
YES |
| 421926 | Rec_0434584 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rattus norvegicus thoracic aorta; endothelium intact with L-NAME 100 μM |
7.6 ± 2.9 % | Maximum vasorelaxation (Emax); endothelium intact with L-NAME 100 μM |
26661890 | - |
YES |
| 421927 | Rec_0434585 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rattus norvegicus endothelium-intact aortic cross sections |
12.3 ± 4.8 % | DAF-FM DA confocal fluorescence increase at 10^-7 M peptide |
26661890 | - |
YES |
| 421928 | Rec_0434586 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rattus norvegicus endothelium-intact aortic cross sections |
13.2 ± 2.4 % | DAF-FM DA confocal fluorescence increase at 10^-5 M peptide |
26661890 | - |
YES |
| 421929 | Rec_0434587 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Human umbilical vascular endothelial cells (HUVECs) |
- | MTT cell viability, 24 h exposure |
26661890 | - |
YES |
| 421930 | Rec_0434588 | BPP-BrachyNH2 |
WPPPKVSP |
synthetic construct [Synthetic] |
- |
Rat aortic vascular smooth muscle cells (VSMCs) |
- | MTT cell viability, 24 h exposure |
26661890 | - |
YES |
| 421931 | Rec_0434589 | Unnamed |
MLVFAV |
Katsuwonus pelamis [Animal] |
- |
- |
- | LC-MS/MS |
- | - |
YES |
| 421932 | Rec_0434590 | Nat-1 |
SASQDDMGPFWANR |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421933 | Rec_0434591 | PK1-1 (N-terminally extended reported product) |
NPGDAKVYRNDKEQSSLGLLDVLRESPLVVVAVNEASKQHNFTPRL |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421934 | Rec_0434592 | ProSAAS-derived peptide |
AVPRGEAAGAVQELARALAHLLEAERQE |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS; LC-FT-ICR MS/MS |
29518334 | - |
YES |
| 421935 | Rec_0434593 | WYGPDRPKFL |
WYGPDRPKFL |
Tetradesmus obliquus [Plant] |
- |
- |
- | RP nanoHPLC-MS/MS |
- | - |
YES |
| 421936 | Rec_0434594 | SWVE |
SWVE |
- |
- |
- |
- | RP-HPLC purification and peptide isolation |
24423562 | - |
YES |
| 421937 | Rec_0434595 | NPFa51-65 [pQ] |
QELDNLYSPRSRPRF |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421938 | Rec_0434596 | NPFa51-65 |
QELDNLYSPRSRPRF |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421939 | Rec_0434597 | NPFb14-28 |
MKLDQLYSSIARPRF |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421940 | Rec_0434598 | ProSAAS-derived peptide |
PRGEAAGAVQELARALAHLLEAERQE |
Rattus norvegicus [Animal] |
- |
- |
- | LC-FT-ICR MS/MS |
29518334 | - |
YES |